These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 38061484)

  • 21. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
    Krystal JH; Sanacora G; Duman RS
    Biol Psychiatry; 2013 Jun; 73(12):1133-41. PubMed ID: 23726151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.
    Drewniany E; Han J; Hancock C; Jones RL; Lim J; Nemat Gorgani N; Sperry JK; Yu HJ; Raffa RB
    J Clin Pharm Ther; 2015 Apr; 40(2):125-30. PubMed ID: 25545040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guanosine as a promising target for fast-acting antidepressant responses.
    Camargo A; Rodrigues ALS
    Pharmacol Biochem Behav; 2022 Jul; 218():173422. PubMed ID: 35732211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.
    Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA
    Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine for Major Depressive Disorder.
    Costi S
    Curr Top Behav Neurosci; 2024; 66():131-147. PubMed ID: 37922100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine.
    Cardona-Acosta AM; Bolaños-Guzmán CA
    Neuropharmacology; 2023 Mar; 225():109374. PubMed ID: 36516891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
    Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
    Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants.
    Gould TD; Zarate CA; Thompson SM
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():213-236. PubMed ID: 30296896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine.
    Wohleb ES; Gerhard D; Thomas A; Duman RS
    Curr Neuropharmacol; 2017; 15(1):11-20. PubMed ID: 26955968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rapid-onset antidepressant effect of ketamine: More surprises?
    Raffa RB; Pergolizzi JV; Taylor R;
    J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants].
    Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C
    Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mGlu2/3 receptor as a novel target for rapid acting antidepressants.
    Chaki S
    Adv Pharmacol; 2020; 89():289-309. PubMed ID: 32616210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research.
    Lv S; Yao K; Zhang Y; Zhu S
    Neuropharmacology; 2023 Mar; 225():109378. PubMed ID: 36539011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
    Kavalali ET; Monteggia LM
    Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The
    Jiang Y; Dong Y; Hu H
    Philos Trans R Soc Lond B Biol Sci; 2024 Jul; 379(1906):20230225. PubMed ID: 38853549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach.
    Scotton E; Casa PL; de Abreu FP; de Avila E Silva S; Wilges RLB; Rossetto MV; Géa LP; Rosa AR; Colombo R
    Pharmacol Biochem Behav; 2023 Feb; 223():173523. PubMed ID: 36731751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine.
    Cui Y; Hu S; Hu H
    Trends Neurosci; 2019 Mar; 42(3):179-191. PubMed ID: 30823984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.
    Duman RS; Shinohara R; Fogaça MV; Hare B
    Mol Psychiatry; 2019 Dec; 24(12):1816-1832. PubMed ID: 30894661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.